About (click to open/close)
Dr Serah Kimani completed an MSC in Structural Biology and a PhD in Molecular and Cell Biology at the University of Cape Town (UCT) under supervision of Prof Trevor Sewell, conducting research on the catalytic mechanism of amidase enzymes. After her PhD, Serah undertook a postdoctoral fellowship in Medical Cell Biology under the guidance of Professor Sharon Prince at UCT, focusing her research on the discovery of anti-cancer compounds. Dr Kimani then moved to Toronto (Canada), and has spent the last 5 years at the Structural Genomics Consortium (University of Toronto), studying E3 ubiquitin ligases and their applications in targeted protein degradation, and contributing in multiple high-impact drug discovery studies.

